Latest News and Press Releases

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Asulon Therapeutics, Inc., which develops novel small molecules for the treatment of mental health...

NEW YORK, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that ColdSteel Laser, Inc. (http://www.coldsteellaser.com), which is developing an endoscopic image guided...

NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that PepVax, Inc. (http://www.pepvax.co), which is developing a therapeutic treatment against triple...

NEW YORK, Sept. 08, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in New York and Philadelphia-based PainQx, Inc., which has developed an...

NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) -- Cerus Endovascular Ltd., one of Mid Atlantic Bio Angels’ (MABA) portfolio companies, recently announced receipt of CE Mark approval for the commercial...

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that Recensa Therapeutics (http://www.recensatherapeutics.com), which is developing a topical psoriasis...

NEW YORK, May 01, 2017 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that BioCurrent Technologies (BioCurrent), a microbe-based, sustainable nanomaterials company, was named...

NEW YORK, April 03, 2017 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Group K Diagnostics (Group K), a diagnostics company developing a multi-test modular point of care...

NEW YORK, March 23, 2017 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that OneThree Biotech (OneThree), a New York-based company developing artificial intelligence technology...

NEW YORK , Dec. 13, 2016 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that NangioTx, Inc.(http://www.nangiotx.com) was voted as “Best of the Best” among past winners of MABA's...